thanks for posting the article. I don’t think CSL will have anything to be concerned about. I do think the article however is a hatchet job on Aegros. Interviewing so called experts who don’t have any clue as to the intimacy of the technology as they are using a different process entirely(Cohn) . The Aegros technology has evolved and testament to this is the additional hyper immune products they can derive from the plasma.
Aegros have some fantastic people (operations, R&d ,scientific advisory) with depth and I am confident this business will succeed.
I am a shareholder in Aegros
Csl sounds pretty safe, page-4
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$282.00 |
Change
0.660(0.23%) |
Mkt cap ! $136.2B | |||
| Open | High | Low | Value | Volume |
| $283.00 | $284.64 | $281.65 | $164.0M | 579.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3 | $282.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $282.02 | 469 | 2 |
View Market Depth
| Last trade - 16.10pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$282.49 |
Change
0.660 ( 0.53 %) |
||||
| Open | High | Low | Volume | ||
| $283.00 | $284.55 | $281.72 | 36821 | ||
| Last updated 15.59pm 04/06/2024 ? | |||||
| CSL (ASX) Chart |